For: | Mix M, Singh AK, Tills M, Dibaj S, Groman A, Jaggernauth W, Rustum Y, Jameson MB. Randomized phase II trial of selenomethionine as a modulator of efficacy and toxicity of chemoradiation in squamous cell carcinoma of the head and neck. World J Clin Oncol 2015; 6(5): 166-173 [PMID: 26468453 DOI: 10.5306/wjco.v6.i5.166] |
---|---|
URL: | https://www.wjgnet.com/2218-4333/full/v6/i5/166.htm |
Number | Citing Articles |
1 |
Soo Jin Park, Ga Won Yim, Haerin Paik, Nara Lee, Seungmee Lee, Maria Lee, Hee Seung Kim. Efficacy and safety of intravenous administration of high-dose selenium for preventing chemotherapy-induced peripheral neuropathy in platinum-sensitive recurrent ovarian, fallopian or primary peritoneal cancer: study protocol for a phase III, double-blind, randomized study. Journal of Gynecologic Oncology 2021; 32(5) doi: 10.3802/jgo.2021.32.e73
|
2 |
Krishnanand Mishra, Ghazi Alsbeih. Appraisal of biochemical classes of radioprotectors: evidence, current status and guidelines for future development. 3 Biotech 2017; 7(5) doi: 10.1007/s13205-017-0925-0
|
3 |
Philippe Collery. Strategies for the development of selenium-based anticancer drugs. Journal of Trace Elements in Medicine and Biology 2018; 50: 498 doi: 10.1016/j.jtemb.2018.02.024
|
4 |
Stephen O. Evans, Gregory M. Jacobson, Hugh J. B. Goodman, Steve Bird, Michael B. Jameson. Comparative Safety and Pharmacokinetic Evaluation of Three Oral Selenium Compounds in Cancer Patients. Biological Trace Element Research 2019; 189(2): 395 doi: 10.1007/s12011-018-1501-0
|
5 |
Heng Wee Tan, Hai-Ying Mo, Andy T. Y. Lau, Yan-Ming Xu. Selenium Species: Current Status and Potentials in Cancer Prevention and Therapy. International Journal of Molecular Sciences 2018; 20(1): 75 doi: 10.3390/ijms20010075
|
6 |
Hye Ri Han, Gregory M. Hermann, Sung Jun Ma, Austin J. Iovoli, Kimberly E. Wooten, Hassan Arshad, Vishal Gupta, Ryan P. McSpadden, Moni A. Kuriakose, Michael R. Markiewicz, Jon M. Chan, Mary E. Platek, Andrew D. Ray, Fangyi Gu, Wesley L. Hicks, Elizabeth A. Repasky, Anurag K. Singh. Matched pair analysis to evaluate the impact of hospitalization during radiation therapy as an early marker of survival in head and neck cancer patients. Oral Oncology 2020; 109: 104854 doi: 10.1016/j.oraloncology.2020.104854
|
7 |
Felix Krannich, Ralph Mücke, Jens Büntzel, Lutz Schomburg, Oliver Micke, Jutta Hübner, Jennifer Dörfler. A systematic review of Selenium as a complementary treatment in cancer patients. Complementary Therapies in Medicine 2024; 86: 103095 doi: 10.1016/j.ctim.2024.103095
|
8 |
Antoni Sureda, Xavier Capó, Silvia Tejada. Nutraceuticals and Cancer Signaling. Food Bioactive Ingredients 2021; : 545 doi: 10.1007/978-3-030-74035-1_20
|
9 |
Cristina W. Nogueira, Nilda V. Barbosa, João B. T. Rocha. Toxicology and pharmacology of synthetic organoselenium compounds: an update. Archives of Toxicology 2021; 95(4): 1179 doi: 10.1007/s00204-021-03003-5
|
10 |
Ami Patel-Yadav, Anurag Singh. Acupuncture-like transcutaneous nerve stimulation therapy success after 5 years post-radiation-induced xerostomia: a case report. Journal of Radiotherapy in Practice 2016; 15(2): 215 doi: 10.1017/S1460396915000576
|
11 |
Mei Yang, Bo Pei, Qiancheng Hu, Xiaoying Li, Xiping Fang, Xue Huang, Zunjing Yang, Jiaquan Chen, Du He, Guogen Sun, Peng Lv, Li Wang, Zixiong Zhang, Lin Lai, Chuying Huang. Effects of selenium supplementation on concurrent chemoradiotherapy in patients with cervical cancer: A randomized, double-blind, placebo-parallel controlled phase II clinical trial. Frontiers in Nutrition 2023; 10 doi: 10.3389/fnut.2023.1094081
|
12 |
Bagher Farhood, Keywan Mortezaee, Elahe Motevaseli, Hanifeh Mirtavoos‐Mahyari, Dheyauldeen Shabeeb, Ahmed Eleojo Musa, Nafiseh Sadat Sanikhani, Masoud Najafi, Amirhossein Ahmadi. Selenium as an adjuvant for modification of radiation response. Journal of Cellular Biochemistry 2019; 120(11): 18559 doi: 10.1002/jcb.29171
|
13 |
V.G. Deepagan, Seunglee Kwon, Dong Gil You, Van Quy Nguyen, Wooram Um, Hyewon Ko, Hansang Lee, Dong-Gyu Jo, Young Mo Kang, Jae Hyung Park. In situ diselenide-crosslinked polymeric micelles for ROS-mediated anticancer drug delivery. Biomaterials 2016; 103: 56 doi: 10.1016/j.biomaterials.2016.06.044
|